Why Isn’t My Antidepressant Working? A Guide to Treatment-Resistant Depression
September 21, 2026
You’ve been taking routine pills. Weeks have passed, maybe months, and you still feel the same. If that’s where you are, you need to know this one thing: you’re not alone, and you haven’t done anything wrong. When depression doesn’t respond to standard antidepressants after a couple of attempts, there’s a clinical term for that pattern. It is called treatment-resistant depression, or TRD.
And that’s why this guide exists. This guide covers what TRD actually means, the signs your medication isn’t working, why antidepressants fail more than people expect, and what tends to help from here.
What Does It Mean When Antidepressants Aren’t Working?
Common Signs Your Antidepressant Isn’t Working
A few patterns tend to show up: mood improves briefly then plateaued, doses keep increasing without payoff, side effects outweigh the benefit, or you’re functional on the surface but flat underneath. None of this means you’re doing something wrong – bring it to your prescriber rather than living with it quietly.
How Long to Give a Medication Before Considering a Change
Antidepressants need four to eight weeks at an adequate dose before you can fairly judge them. Stopping earlier often means it never got a real chance. Severe side effects or feeling worse, not better, is worth an immediate call.
The Difference Between Partial Response and No Response
No response means nothing moved. Partial response means some symptoms eased but you’re still clearly depressed – and it’s actually the more common outcome. It often gets mistaken for “as good as it gets,” when it usually means the approach needs adjusting, not abandoning.
What Is Treatment-Resistant Depression?
The Clinical Definition: Failing Two or More Antidepressants
Most clinicians define TRD as depression that hasn’t improved enough after two different antidepressants, each given at an adequate dose for an adequate length of time – a pattern, not a judgment about effort or severity.
Why Some Depression Doesn’t Respond to Standard Medication
Standard antidepressants raise serotonin. But persistent depression increasingly looks like it involves more than one brain system – reduced connectivity between regions, not just a shortage of one chemical. A serotonin-only medication may simply be targeting the wrong part of the problem.
How Common Is Treatment-Resistant Depression?
More common than most assume. In the STAR*D study – the largest real-world depression treatment trial ever run – about half of participants responded to their first antidepressant, but only 30 percent reached full remission. By the fourth attempt, cumulative remission reached around 67 percent, though roughly a third of patients still hadn’t fully recovered.
Why Antidepressants Stop Working (or Never Start)
Serotonin Isn’t the Whole Story
If a serotonin-raising medication isn’t helping, it may just mean serotonin wasn’t the right target. Glutamate, an entirely different brain system, has become a major focus of newer depression treatment for this reason.
Genetics, Dosing, and Individual Response
Genetics affect how your liver metabolizes certain antidepressants, which can mean a standard dose barely registers or causes side effects severe enough to derail the trial early. Dosing isn’t “more is better” either – response tends to follow a bell curve, improving to a point and tapering off past it.
When It’s Misdiagnosis, Not Medication Failure
An untreated thyroid condition, unmanaged stress, or anxiety alongside depression can blunt how well a medication works, even with an accurate diagnosis. A missed bipolar diagnosis is particularly worth ruling out, since antidepressants can behave differently there.
Wondering if your depression fits this pattern? See if you qualify →
What to Do When Antidepressants Aren’t Working
Talking to Your Prescriber About Next Steps
Bring a clear history: what you tried, how long, at what dose, what happened. “I was on 20mg for two months and felt maybe 10 percent better before plateauing” gives a provider far more to work with than “it didn’t work.”
Augmentation Strategies vs. Switching Medications
Augmentation means adding a second medication – lithium or a low-dose atypical antipsychotic – alongside your current one. Switching means moving to a different medication or class entirely, like an SNRI or an older option like an MAOI. Which fits depends on whether you had any partial response and your side effect history.
When It’s Time to Explore Options Beyond Oral Antidepressants
After two or more adequate trials without real improvement, it’s reasonable to look past pills, toward treatments working through a different brain mechanism entirely.
Treatment Options for Treatment-Resistant Depression
Spravato (Esketamine): FDA-Approved for TRD
Spravato is a nasal spray form of esketamine, the only ketamine-derived medication with full FDA approval for TRD. It works through the glutamate system, given in a certified clinic with a required two-hour monitoring period. Our full guide to Spravato treatment covers what a course actually involves.
IV/IM Ketamine Therapy
IV and intramuscular ketamine are used off-label for depression, lacking Spravato’s FDA approval despite substantial supporting research. Dosing is more flexible session to session, but insurance coverage is far less consistent. This comparison breaks down the differences in more detail.
TMS (Transcranial Magnetic Stimulation)
TMS uses magnetic pulses to stimulate brain regions involved in mood, with no medication, sedation, or observation time. It’s FDA-cleared for depression, involving daily sessions over several weeks. Read more about how TMS works if it sounds like a fit.
Combining Medication With Therapy
Structured therapy alongside medication or Spravato tends to support better outcomes than either alone, especially once depression has reached the treatment-resistant stage.
Curious how Spravato works? Read the science →
What Makes Spravato Different From Traditional Antidepressants
Targeting NMDA Receptors Instead of Serotonin
Esketamine blocks NMDA receptors, indirectly increasing glutamate activity in areas like the prefrontal cortex – a different mechanism than SSRIs, which keep more serotonin available over time.
Faster Onset of Relief
Because it works through a faster-acting pathway, some patients notice a shift within hours to days, particularly those treated for acute suicidal ideation – far faster than the typical four-to-eight-week wait for a new antidepressant.
FDA-Approval Specifically for Treatment-Resistant Depression
This is what separates Spravato from IV or IM ketamine most concretely – formal FDA trials for this exact indication, which is why coverage tends to be more consistent and dosing more standardized.
Getting Help for Treatment-Resistant Depression at Marpa Minds
Insurance-Covered, FDA-Approved Care
Marpa Minds verifies insurance benefits and manages prior authorization directly. Most major plans and Medicare Part B cover Spravato once approved, and Marpa Minds is an approved VA Community Care provider with Tricare coverage.
Locations in Westchester and Rockland County
Marpa Minds runs a flagship clinic in White Plains, Westchester County, plus a Rockland County location – closing a real gap for patients who once had to cross the Hudson for care. Read more about the White Plains clinic if you’re nearby.
A Supportive, Spa-Like Clinical Environment
Since treatment involves sitting with a provider for an extended observation period, the setting matters. Marpa Minds built its clinics to feel like a quiet, private space rather than a standard waiting room.
Frequently Asked Questions
How do I know if I have treatment-resistant depression?
If two or more antidepressants, each given a full trial, haven’t brought enough relief, that pattern generally meets the definition. A provider evaluation confirms it.
How many antidepressants do I need to try before being considered treatment-resistant?
Two, at an adequate dose for an adequate length of time, is the most commonly used threshold.
Can treatment-resistant depression be treated?
Yes. It’s a pattern, not a permanent condition. Augmentation, switching medications, therapy, Spravato, and TMS all offer real paths forward.
What’s the difference between treatment-resistant depression and regular depression?
Severity isn’t the distinguishing factor – response to standard treatment is. Two people with similar symptoms can respond very differently to the same medication.
Is Spravato effective for treatment-resistant depression?
In a 2023 trial against quetiapine, about 27 percent of the Spravato group reached remission by eight weeks, rising to nearly 50 percent by 32 weeks. Results vary by individual.
How long does it take to find out if a new treatment is working?
About four weeks for Spravato’s induction phase, and four to eight weeks for a standard antidepressant, though some patients notice change sooner.
This article is for informational purposes and isn’t a substitute for medical advice. Talk with a licensed clinician about your specific treatment history and what options may be appropriate for you.
Ready to explore treatment that works? Get Started Now →
About Author
